Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Drinking plenty of water before, during, and after the dose increase helps your digestive system adjust and reduces nausea
A simple X-plus-Y-equals-Z formula
Retatrutide (LY-3437943) is an investigational drug developed by Eli Lilly that acts as a triple hormone receptor agonist : GLP-1 (glucagon-like peptide-1) receptor agonist GIP (glucose-dependent insulinotropic polypeptide) receptor agonist Glucagon receptor agonist - read about why this is so important here This triagonist approach amplifies the metabolic impact seen with GLP-1 and GIP combinations like tirzepatide, while also leveraging glucagons thermogenic and energy-expending properties
Retatrutide is supplied in 5mg, 10mg, 20mg, 30mg and 60mg research strengths
Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects
If you take less than the recommended dose, you may have fewer side effects that week, but when you take your next shot, its as if youre starting over
US$ 29.34
US$ 28.50
US$ 29.93
US$ 28.73
